Misonix, now a part of Bioventus, specializes in developing and providing minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. These products are designed to improve surgical outcomes and patient recovery times. The company serves a diverse range of clients including hospitals, surgical centers, and specialized medical practitioners. Operating in the medical technology market, Misonix's business model revolves around the research, development, and commercialization of advanced medical devices. Revenue is generated through the direct sale of these devices and products to healthcare providers, as well as through partnerships and collaborations with other medical technology firms. Misonix's innovative solutions are particularly noted for their applications in neurosurgery, spinal surgery, and wound care, where they offer significant advantages in terms of precision, safety, and cost-effectiveness.

Keywords: ultrasonic medical devices, regenerative tissue products, minimally invasive, surgical outcomes, neurosurgery, spinal surgery, wound care, healthcare providers, medical technology, Bioventus.